ID   SYTM_HUMAN              Reviewed;         718 AA.
AC   Q9BW92; Q53GW7; Q96I50; Q9H9V2;
DT   31-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   15-MAR-2017, entry version 142.
DE   RecName: Full=Threonine--tRNA ligase, mitochondrial;
DE            EC=6.1.1.3 {ECO:0000269|PubMed:26811336};
DE   AltName: Full=Threonyl-tRNA synthetase;
DE            Short=ThrRS;
DE   AltName: Full=Threonyl-tRNA synthetase-like 1;
DE   Flags: Precursor;
GN   Name=TARS2; Synonyms=TARSL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   IDENTIFICATION.
RX   PubMed=15779907; DOI=10.1021/bi047527z;
RA   Bonnefond L., Fender A., Rudinger-Thirion J., Giege R., Florentz C.,
RA   Sissler M.;
RT   "Toward the full set of human mitochondrial aminoacyl-tRNA
RT   synthetases: characterization of AspRS and TyrRS.";
RL   Biochemistry 44:4805-4816(2005).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J.,
RA   Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V.,
RA   Blagoev B.;
RT   "System-wide temporal characterization of the proteome and
RT   phosphoproteome of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9]
RP   INVOLVEMENT IN COXPD21, VARIANT COXPD21 LEU-282, AND CHARACTERIZATION
RP   OF VARIANT COXPD21.
RX   PubMed=24827421; DOI=10.1002/humu.22590;
RA   Diodato D., Melchionda L., Haack T.B., Dallabona C., Baruffini E.,
RA   Donnini C., Granata T., Ragona F., Balestri P., Margollicci M.,
RA   Lamantea E., Nasca A., Powell C.A., Minczuk M., Strom T.M.,
RA   Meitinger T., Prokisch H., Lamperti C., Zeviani M., Ghezzi D.;
RT   "VARS2 and TARS2 mutations in patients with mitochondrial
RT   encephalomyopathies.";
RL   Hum. Mutat. 35:983-989(2014).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBUNIT, BIOPHYSICOCHEMICAL PROPERTIES,
RP   AND CHARACTERIZATION OF VARIANT COXPD21 LEU-282.
RX   PubMed=26811336; DOI=10.1074/jbc.M115.700849;
RA   Wang Y., Zhou X.L., Ruan Z.R., Liu R.J., Eriani G., Wang E.D.;
RT   "A human disease-causing point mutation in mitochondrial threonyl-tRNA
RT   synthetase induces both structural and functional defects.";
RL   J. Biol. Chem. 291:6507-6520(2016).
CC   -!- FUNCTION: Catalyzes the attachment of threonine to tRNA(Thr) in a
CC       two-step reaction: threonine is first activated by ATP to form
CC       Thr-AMP and then transferred to the acceptor end of tRNA(Thr).
CC       Also edits incorrectly charged tRNA(Thr) via its editing domain.
CC       {ECO:0000269|PubMed:26811336}.
CC   -!- CATALYTIC ACTIVITY: ATP + L-threonine + tRNA(Thr) = AMP +
CC       diphosphate + L-threonyl-tRNA(Thr). {ECO:0000269|PubMed:26811336}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.5 mM for L-threonine {ECO:0000269|PubMed:26811336};
CC         KM=1.1 uM for tRNA(Thr) {ECO:0000269|PubMed:26811336};
CC         KM=180 mM for L-serine {ECO:0000269|PubMed:26811336};
CC         Note=kcat is 5.8 sec(-1) for the activation reaction of L-
CC         threonine. kcat is 1.1 sec(-1) for the activation reaction of L-
CC         serine. kcat is 0.061 sec(-1) for the aminoacylation of
CC         tRNA(Thr) with L-threonine. {ECO:0000269|PubMed:26811336};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:26811336}.
CC   -!- SUBCELLULAR LOCATION: Mitochondrion matrix {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BW92-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BW92-2; Sequence=VSP_054537;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Combined oxidative phosphorylation deficiency 21
CC       (COXPD21) [MIM:615918]: A mitochondrial disorder characterized by
CC       a lethal encephalomyopathy. Shortly after birth, affected
CC       individuals manifest axial hypotonia, limb hypertonia, psychomotor
CC       delay, and increased serum lactate. Additional features include
CC       subsarcolemmal lipofuscin-positive deposits in muscle, cerebral
CC       spongiosis, and hepatic steatosis. {ECO:0000269|PubMed:24827421,
CC       ECO:0000269|PubMed:26811336}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the class-II aminoacyl-tRNA synthetase
CC       family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AK022590; BAB14117.1; -; mRNA.
DR   EMBL; AK222814; BAD96534.1; -; mRNA.
DR   EMBL; AL356356; CAI15488.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53549.1; -; Genomic_DNA.
DR   EMBL; BC000541; AAH00541.1; -; mRNA.
DR   EMBL; BC007824; AAH07824.2; -; mRNA.
DR   EMBL; BC009997; AAH09997.1; -; mRNA.
DR   CCDS; CCDS60252.1; -. [Q9BW92-2]
DR   CCDS; CCDS952.1; -. [Q9BW92-1]
DR   RefSeq; NP_001258825.1; NM_001271896.1. [Q9BW92-2]
DR   RefSeq; NP_079426.2; NM_025150.4. [Q9BW92-1]
DR   UniGene; Hs.288974; -.
DR   ProteinModelPortal; Q9BW92; -.
DR   SMR; Q9BW92; -.
DR   BioGrid; 123188; 12.
DR   IntAct; Q9BW92; 13.
DR   MINT; MINT-8052579; -.
DR   STRING; 9606.ENSP00000358060; -.
DR   ChEMBL; CHEMBL3351186; -.
DR   DrugBank; DB00156; L-Threonine.
DR   iPTMnet; Q9BW92; -.
DR   PhosphoSitePlus; Q9BW92; -.
DR   DMDM; 74752395; -.
DR   EPD; Q9BW92; -.
DR   MaxQB; Q9BW92; -.
DR   PaxDb; Q9BW92; -.
DR   PeptideAtlas; Q9BW92; -.
DR   PRIDE; Q9BW92; -.
DR   Ensembl; ENST00000369054; ENSP00000358050; ENSG00000143374. [Q9BW92-2]
DR   Ensembl; ENST00000369064; ENSP00000358060; ENSG00000143374. [Q9BW92-1]
DR   GeneID; 80222; -.
DR   KEGG; hsa:80222; -.
DR   UCSC; uc001euq.5; human. [Q9BW92-1]
DR   CTD; 80222; -.
DR   DisGeNET; 80222; -.
DR   GeneCards; MIR6878; -.
DR   GeneCards; TARS2; -.
DR   HGNC; HGNC:30740; TARS2.
DR   HPA; HPA028626; -.
DR   MalaCards; TARS2; -.
DR   MIM; 612805; gene.
DR   MIM; 615918; phenotype.
DR   neXtProt; NX_Q9BW92; -.
DR   OpenTargets; ENSG00000143374; -.
DR   PharmGKB; PA162405200; -.
DR   eggNOG; KOG1637; Eukaryota.
DR   eggNOG; COG0441; LUCA.
DR   GeneTree; ENSGT00390000002149; -.
DR   HOGENOM; HOG000003878; -.
DR   HOVERGEN; HBG059513; -.
DR   InParanoid; Q9BW92; -.
DR   KO; K01868; -.
DR   OMA; TVYGCGM; -.
DR   OrthoDB; EOG091G01UL; -.
DR   PhylomeDB; Q9BW92; -.
DR   TreeFam; TF300858; -.
DR   Reactome; R-HSA-379726; Mitochondrial tRNA aminoacylation.
DR   ChiTaRS; TARS2; human.
DR   GenomeRNAi; 80222; -.
DR   PRO; PR:Q9BW92; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143374; -.
DR   CleanEx; HS_TARS2; -.
DR   ExpressionAtlas; Q9BW92; baseline and differential.
DR   Genevisible; Q9BW92; HS.
DR   GO; GO:0005759; C:mitochondrial matrix; IEA:UniProtKB-SubCell.
DR   GO; GO:0005739; C:mitochondrion; IBA:GO_Central.
DR   GO; GO:0002161; F:aminoacyl-tRNA editing activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0004829; F:threonine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0070159; P:mitochondrial threonyl-tRNA aminoacylation; TAS:BHF-UCL.
DR   CDD; cd00771; ThrRS_core; 1.
DR   Gene3D; 3.10.20.30; -; 1.
DR   Gene3D; 3.40.50.800; -; 1.
DR   HAMAP; MF_00184; Thr_tRNA_synth; 1.
DR   InterPro; IPR002314; aa-tRNA-synt_IIb.
DR   InterPro; IPR006195; aa-tRNA-synth_II.
DR   InterPro; IPR004154; Anticodon-bd.
DR   InterPro; IPR012675; Beta-grasp_dom.
DR   InterPro; IPR004095; TGS.
DR   InterPro; IPR012676; TGS-like.
DR   InterPro; IPR002320; Thr-tRNA-ligase_IIa.
DR   InterPro; IPR018163; Thr/Ala-tRNA-synth_IIc_edit.
DR   InterPro; IPR033728; ThrRS_core.
DR   InterPro; IPR012947; tRNA_SAD.
DR   PANTHER; PTHR11451; PTHR11451; 1.
DR   Pfam; PF03129; HGTP_anticodon; 1.
DR   Pfam; PF02824; TGS; 1.
DR   Pfam; PF00587; tRNA-synt_2b; 1.
DR   Pfam; PF07973; tRNA_SAD; 1.
DR   PRINTS; PR01047; TRNASYNTHTHR.
DR   SMART; SM00863; tRNA_SAD; 1.
DR   SUPFAM; SSF52954; SSF52954; 1.
DR   SUPFAM; SSF55186; SSF55186; 1.
DR   SUPFAM; SSF81271; SSF81271; 1.
DR   TIGRFAMs; TIGR00418; thrS; 1.
DR   PROSITE; PS50862; AA_TRNA_LIGASE_II; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Complete proteome; Disease mutation; Ligase; Mitochondrion;
KW   Nucleotide-binding; Phosphoprotein; Protein biosynthesis;
KW   Reference proteome; Transit peptide.
FT   TRANSIT       1      ?       Mitochondrion. {ECO:0000255}.
FT   CHAIN         ?    718       Threonine--tRNA ligase, mitochondrial.
FT                                /FTId=PRO_0000254586.
FT   MOD_RES      52     52       Phosphoserine.
FT                                {ECO:0000244|PubMed:21406692}.
FT   VAR_SEQ     211    340       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_054537.
FT   VARIANT     282    282       P -> L (in COXPD21; decreased expression
FT                                at mRNA and protein levels; decreased
FT                                threonine-tRNA ligase activity; affects
FT                                both Thr activation and transfer;
FT                                decreased aminoacyl-tRNA editing
FT                                activity; decreased protein stability;
FT                                loss of homodimerization;
FT                                dbSNP:rs587777593).
FT                                {ECO:0000269|PubMed:24827421,
FT                                ECO:0000269|PubMed:26811336}.
FT                                /FTId=VAR_071853.
FT   CONFLICT    269    269       A -> P (in Ref. 2; BAD96534).
FT                                {ECO:0000305}.
FT   CONFLICT    579    579       E -> G (in Ref. 2; BAD96534).
FT                                {ECO:0000305}.
SQ   SEQUENCE   718 AA;  81036 MW;  A2F793A60483E7F9 CRC64;
     MALYQRWRCL RLQGLQACRL HTAVVSTPPR WLAERLGLFE ELWAAQVKRL ASMAQKEPRT
     IKISLPGGQK IDAVAWNTTP YQLARQISST LADTAVAAQV NGEPYDLERP LETDSDLRFL
     TFDSPEGKAV FWHSSTHVLG AAAEQFLGAV LCRGPSTEYG FYHDFFLGKE RTIRGSELPV
     LERICQELTA AARPFRRLEA SRDQLRQLFK DNPFKLHLIE EKVTGPTATV YGCGTLVDLC
     QGPHLRHTGQ IGGLKLLSNS SSLWRSSGAP ETLQRVSGIS FPTTELLRVW EAWREEAELR
     DHRRIGKEQE LFFFHELSPG SCFFLPRGTR VYNALVAFIR AEYAHRGFSE VKTPTLFSTK
     LWEQSGHWEH YQEDMFAVQP PGSDRPPSSQ SDDSTRHITD TLALKPMNCP AHCLMFAHRP
     RSWRELPLRL ADFGALHRAE ASGGLGGLTR LRCFQQDDAH IFCTTDQLEA EIQSCLDFLR
     SVYAVLGFSF RLALSTRPSG FLGDPCLWDQ AEQVLKQALK EFGEPWDLNS GDGAFYGPKI
     DVHLHDALGR PHQCGTIQLD FQLPLRFDLQ YKGQAGALER PVLIHRAVLG SVERLLGVLA
     ESCGGKWPLW LSPFQVVVIP VGSEQEEYAK EAQQSLRAAG LVSDLDADSG LTLSRRIRRA
     QLAHYNFQFV VGQKEQSKRT VNIRTRDNRR LGEWDLPEAV QRLVELQNTR VPNAEEIF
//
